3rd Therapeutics Discovery
Convention Center, KSAU-HS. 10-11-12 October 2023
2023-10-10 03:00:00
Registration
Abstract Submission
  • ABSTRACT SUBMISSION
  • Home
  • About
    • OBJECTIVES
    • EXECUTIVE DIRECTOR MESSAGE
    • CONFERENCE CHAIRMAN MESSAGE
    • CONTACT US
  • SPEAKERS
    • SPEAKER LIST
    • MEET THE EXPERTS
  • PROGRAM
    • CONFERENCE PROGRAM
    • PRE-CONFERENCE WORKHOPS
  • EVENT DETAILS
    • REGISTERATION
      • ATTEND THE CONFERENCE
    • ABSTRACT SUBMISSION
      • ABSTRACT SUBMISSION
    • CONFERENCE DETAILS
      • ORGANIZERS
    • POSTERS
      • EVENT POSTER
      • POSTER TEMPLATE
      • POSTER GUIDELINES
      • POSTER REVIEW PANEL
    • CME
      • CME
  • Home
  • About
    • OBJECTIVES
    • EXECUTIVE DIRECTOR MESSAGE
    • CONFERENCE CHAIRMAN MESSAGE
    • CONTACT US
  • SPEAKERS
    • SPEAKER LIST
    • MEET THE EXPERTS
  • PROGRAM
    • CONFERENCE PROGRAM
    • PRE-CONFERENCE WORKHOPS
  • EVENT DETAILS
    • REGISTERATION
      • ATTEND THE CONFERENCE
    • ABSTRACT SUBMISSION
      • ABSTRACT SUBMISSION
    • CONFERENCE DETAILS
      • ORGANIZERS
    • POSTERS
      • EVENT POSTER
      • POSTER TEMPLATE
      • POSTER GUIDELINES
      • POSTER REVIEW PANEL
    • CME
      • CME

SPEAKER LIST

Speakers

SPEAKER
SESSION CHAIR

H.E. Dr. Bandar Al Knawy

H.E. Dr. Bandar Al Knawy

MD, FRCPC, FRCP (edin) Chief Executive Officer, Ministry of National Guard Health Affairs President, King Saud bin Abdulaziz University for Health Sciences
Read more
DR.-AHMED-ALASKAR-292x292

Dr. Ahmed Alaskar

Conference President
Read more
DrMohammad-292x250

Dr. Mohamed Boudjelal

Conference Chairman
Read more
5

Dr Ashley McKimm

Editor-in-Chief, BMJ Innovations
Read more
1

Prof. Majid Alfadhel

Deputy Executive Director King Abdullah International Medical Research Center Chairman, Genetics and Precision Medicine Department King Abdulaziz Medical City
Read more
Miriam Merad

Miriam Merad, M.D.

Ph.D. is the Director of the Precision Immunology Institute at Mount Sinai School of Medicine in New York and the Director of the Mount Sinai Human Immune Monitoring Center (HIMC).

Dr. Merad is an internationally acclaimed physician-scientist and a leader in the fields of dendritic cell and macrophage biology with a focus on their contribution to human diseases. Dr. Merad identified the tissue resident  macrophage lineage and revealed its distinct role in organ physiology and pathophysiology. She established the contribution of this macrophage lineage to cancer progression and inflammatory diseases and is now working on the development of novel macrophage-targeted therapies for these conditions. In addition to her work on macrophages, Dr. Merad is known for her work on dendritic cells, a group of cells that control adaptive immunity. She identified a new subset of dendritic cells, which is now considered a key target of antiviral and antitumor immunity.

Dr. Merad leads the Precision Immunology Institute at the Icahn School of Medicine (PrIISM) to bring immunology discoveries to the clinic. PrIISM integrates immunological research programs with synergistic expertise in biology, medicine, technology, physics, mathematics and computational biology to enhance our understanding of human immunology. She also founded the Human Immune Monitoring Center at Mount Sinai, one of the world’s most sophisticated research centers, which uses cutting-edge single-cell technology to understand the contribution of immune cells to major human diseases or treatment responses.  .

Dr. Merad has authored more than 200 primary papers and reviews in high profile journals. Her work has been cited several thousand times. She receives generous funding from the National Institutes of Health (NIH) for her research on innate immunity and their contribution to human disease, and belongs to several NIH consortia. She is an elected member of the American Society of Clinical Investigation and the recipient of the William B. Coley Award for Distinguished Research in Basic and Tumor Immunology. She is the President-elect of the International Union of Immunological Societies (IUIS).  In 2020, she was elected to the National Academy of Sciences in recognition of her contributions to the field of immunology.

Read more
5

Prof. Fowzan S Alkuraya

MD (Hons) ABP ABMGG (Clinical Genetics and Clinical Molecular Genetics) Professor of Human Genetics, Principal Clinical Scientist and Senior Consultant Chairman, Translational Genomics (Center for Genomic Medicine) King Faisal Specialist Hospital and Research Center
Read more
Per-I.-Arvidsson-III

Professor Per I. Arvidsson

Director, Karolinska Institute, Swedish Drug Discovery & Development Platform at Science for Life Laboratory

Per I Arvidsson is Director of the national Swedish Drug Discovery & Development Platform at Science for Life Laboratory (SciLifeLab DDD). He is also a fractional research professor at the College of Health Science, UKZN, and South Africa. Before joining SciLifeLab & Karolinska Institutet in 2013 to set up the SciLifeLab DDD platform, Prof. Arvidsson held various roles at the CNS & Pain iMED at AstraZeneca, Södertälje, the last being Director for late-stage pre-clinical and clinical neuroscience drug discovery. His accolades include several professorship positions at Uppsala University in Sweden and postdoctoral studies with Prof. D. Seebach at ETH Zurich, Switzerland.

Prof. Arvidsson is named inventor on some 15+ patent applications, and co-author to some 100 peer-reviewed publications, two of which have won “most cited papers” awards.

Read more
Dr. James Zou

Dr. James Zou

Biomedical data science, CS and EE at Stanford University
Read more
Essam A. Tawfik

Dr. Essam A. Tawfik

Director of the National Center for Pharmaceutical Technology at King Abdulaziz City for Science and Technology (KACST) Saudi Arabia
Read more
Al Ghobain

Prof. Mohammed Al Ghobain

College of Medicine, KSAU-HS, Consultant Pulmonologist at King Abdulaziz Medical City, MNGHA
Read more
6

Prof. Dr. Claussen

Director Fraunhofer IME ScreeningPort, Hamburg, Head of Fraunhofer “Initiative Medical Data Space”, Germany
Read more
Alhadrami

Dr. Hani Abdullah Alhadrami

Consultant & Associate Professor of Molecular Diagnostics & Medical Biotechnology. Molecular Diagnostics Lab, King Abdulaziz University Hospital. King Fahad Medical Research Center, Jeddah, KSA.
Read more
Dr. Lim Theam Soon

Dr. Lim Theam Soon

Associate Professor at Universiti Sains Malaysia
Read more
Prof. PENG LI

Prof. PENG LI

Principal Investigator, Guangzhou Institutes of Biomedicine and Health, CAS (Guangzhou, China)
Read more
Dr. Steve Pascolo

Dr. Steve Pascolo

Founder And CEO Miescher Pharma GmbH mRNA-based vaccines and therapies - Chloroquine Zurich, Switzerland
Read more
Prof. Hang Yang

Prof. Hang Yang

CAS Key Laboratory of Special Pathogens and Biosafety, Centre for Biosafety Mega-Science, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China
Read more
9

Dr. Shahul Nilar

Director, Computational Chemistry at Global Blood Therapeutics South San Francisco, California, United State
Read more
11

Dr Kanan Alshammari

Medical Oncology Consultant - GI, sarcoma Department of Medical Oncology King Abdulaziz Medical City - Central Region Riyadh, Saudi Arabia
Read more
12

Dr. Mohammad Bosaeed

Infectious Disease Consultant, Department of Medicine, King Abdulaziz Medical city, Riyadh, Saudi Arabia. Assistant Professor, college of medicine, King Saud bin Abdulaziz University for Health Sciences. Associate director of clinical trial services, KAIMRC.
Read more
Ryan Copping

Dr. Ryan Copping

Global Head of Data Science Acceleration (DSX) ; PD Data Sciences, Product Development (PD), Roche & Genentech, South San Francisco, CA 94080
Read more
Arvidsson

Dr. Per Iverson

PhD, Professor Director Drug Discovery & Development Science for Life Laboratory Stockholm Medical Biochemistry & Biophysics Karolinska Institutet Box 1031, S-171 21 Solna, Sweden
Read more
Cesar-Sanz-Rodriguez new

Cesar Sanz Rodriguez

MD PhD Vice President, Medical Affairs EMEA Moderna
Read more
Dr. Alex Zhavoronkov

Dr. Alex Zhavoronkov,

Founder and CEO of Insilico Medicine (insilico.com),
Read more
Dr. Ahmed Alkhaldi

Dr. Ahmed Alkhaldi,

Head of clinical studies at the Saudi Food and Drug Authority.
Read more
Dr Nessar Ahmed

Dr Nessar Ahmed

PhD CSci FIBMS , Reader in Clinical Biochemistry, Department of Life Sciences, Manchester Metropolitan University, UK.
Read more
Prof. Paul Robbins

Prof. Paul Robbins

Dr. Robbins received his B.A. from Haverford College, his Ph.D. from the University of California at Berkeley and then worked as a post-doctoral fellow in the laboratory of Dr. Richard Mulligan at the Whitehead Institute at MIT. He was an Assistant, Associate and then full Professor of Microbiology and Molecular Genetics at the University of Pittsburgh School of Medicine as well as Director of Basic Research for the Molecular Medicine Institute and Co-Director of the Paul Wellstone Cooperative Muscular Research Center. He then was a Professor of Molecular Medicine at Scripps Research in Jupiter, Florida and Director of the Center on Aging.

He currently is a Professor of Biochemistry, Molecular Biology and Biophysics and Associate Director of the Institute on the Biology of Aging and Metabolism at the University of Minnesota. His current research is focused on developing therapeutic approaches to extend healthspan. He has co-authored more than 385 peer-reviewed manuscripts and 205 book chapters and reviews with an H-index of 133, i10-index of 483 and ~68,000 citations and has edited four books.

Read more
Dr. Naheed Kurji

Dr. Naheed Kurji

Naheed is the Co-founder, President and CEO of Cyclica, a leading AI in drug discovery company that advances molecules to medicines by embracing the complexity of the disease. In addition to his role at Cyclica, Naheed is also a Co-founder and Board Member of EntheogeniX Biosciences, a psychedelic inspired biotech company for mental health, Board Chair of the Alliance for Artificial Intelligence in Healthcare (AAIH), Board Member of the Ontario Bioscience Innovation Organization (OBIO), and Member of the Life Sciences Advisory Group for Global Affairs Canada. Naheed is passionate about how people interact with technology to inform effective decision making, while dedicated to advancing the responsible application of AI to healthcare and the impact on patients. Naheed holds an MBA from Rotman School of Business, an undergraduate degree from the University of Ottawa, and a certificate in AI from MIT.

Read more
Prof.-Dr.-Michael-Hust

Prof. Dr. Michael Hust

Technische Universität Braunschweig

Michael studied biology at the Carl von Ossietzky Universität in Oldenburg, Germany, from 1993-1999. He received his PhD from the Leibniz Universität in Hannover, Germany, in 2002. Since end of 2002 he is working as group leader at the Technische Universität Braunschweig, Germany. In 2011, he finished his professorial dissertation (Habilitation) and was appointed as Privatdozent (PD). In 2014 he was appointed as professor for biotechnology and in 2022 he became head of the Medical Biotechnology department. Michael published more than 170 articles and filed several patents in the field of antibody engineering and phage display. He is co-author of the German text book „Rekombinante Antikörper“ and editor of the book „Phage Display“. His research passion is the development of recombinant antibodies and antibody engineering for diagnostics and therapy with a focus on infectious diseases and toxins as well as the identification of biomarkers of pathogens using ORFeome phage display. He co-founded four biotech companies including YUMAB GmbH and CORAT Therapeutics.

Read more
Dr.-Mamoon-Rashid new

Dr. Mamoon Rashid

Associate Research Scientist in King Abdullah International Medical Research Center (KAIMRC).

Mamoon Rashid is currently an Associate Research Scientist in King Abdullah International Medical Research Center (KAIMRC). He holds a PhD degree in Bioinformatics jointly from Institute of Microbial Technology and Jawaharlal Nehru University, India under Dr. GPS Raghava. He obtained a post-doctoral fellowship in King Abdullah University of Science and Technology under Prof. Arnab Pain and Prof. Uli Stingl.

He was one of the team members of Open Source Drug Discovery (OSDD) initiative by Government of India. He developed many machine learning-based prediction models for functional annotation of Mycobacterial and human genome. He has expertise in next-generation sequencing data (Whole genome sequencing, Whole exome sequencing, RNA-Seq, and Chip-Seq etc.) analysis and downstream analysis for biomedical research. He has a solid understanding of different types of genomic assays and their bioinformatics analyses and their implications in biomedical research.
Currently, in KAIMRC he is focusing on cancer genomics specifically breast cancer and blood cancers to identify “cancer antigens or neoantigens” leading to the development pf personalized cancer vaccine or therapy development.

Read more
Ms-Rania-Ahmed-Haddadi 1

Ms Rania Ahmed Haddadi

Very curious, she is passionate about science and experiences.
PhD candidate in cell and molecular biology, Zoology Department, College of Science, King Saud University, Riyadh, Saudi Arabia
Master of Forensic Science (Entomology), Zoology Department, College of Science, King Saud University, Riyadh, Saudi Arabia
Bachelor of Molecular Biology and Biotechnology, Biology Department, College of Science, Princess Noura Bint Abdulrahman University, Riyadh, Saudi Arabia

Read more
Mrs Profile

Mrs. Ghida Dairi

Master’s degree in Experimental Medicine (Molecular and Cellular Physiology), the Faculty of Medicine, University of British Columbia, Canada
Bachelor’s degree in Laboratory Medicine, Faculty of Applied Medical Science, Umm Al-Qura University
Ph.D. Student in Clinical Physiology (Molecular Physiology) Faculty of Medicine, King Saud University, Riyadh

Read more
Mrs Profile

Mrs. Tahani Hassan Asirio

Research Interests: Molecular basis of disease, and Drug Discovery PhD student at the Department of Zoology, King Saud University, Riyadh
Bachelor’s and Master’s in Biology from Biology Department, King Khalid University, Abha
Member of the Saudi Society of Molecular Biology and Biotechnology

Read more
Mrs.-Amani-Al-Sharidah new

Mrs. Amani Al-Sharidah

In year 2011, Ms. Amani Al-Sharidah graduated with a bachelor’s degree in biology followed by a master’s degree in physiology from King Saud University, Riyadh, Saudi Arabia. Ms. Al- Sharidah has worked as a research assistant and university lecturer in several medical institutes and research centers in Saudi Arabia. Ms. Al-Sharidah is currently a doctoral student at King Saud University and King Abdullah International Medical Research Center, Riyadh, Saudi Arabia. Ms. Al-Sharidah main research interest is in experimental pharmacology of natural products and their bioactive constituents in animals and humans. Ms. Al-Sharidah has also attended numerous scientific, technical, and vocational courses.

Read more
Mrs Profile

Mrs. Saba ALSubaie

I am a Ph.D student at College of Sciences (Department of Zoology ) , King Saud University (KSU). In 2020 I received Master Degree in Science in Zoology from KSU Riyadh. Earlier I had a Bachelor in Biology from Princess Nora Bint Abdul Rahman University, Riyadh. 2010 – May 2014. I also have a General Diploma of Education from Bisha University, Bisha.

Read more
Instructors

Courses
Instructors

Dr. Mohammed Alfaleh

Dr. Mohammed Alfaleh

Faculty of pharmacy at King Abdulaziz University
Read more
Baker

Dr. Ahmed Mohamoud Baker

Cancer Immunotherapy Assistant Professor - College of Applied Medical Sciences Vice Dean of Scientific Research for Technical Affairs and Development Clinical Laboratory Science Department
Read more
Sabban

Dr. Sari Sabban

Molecular Biologist and Biotechnologist
Read more
Alshazi

Dr. Mashal M. Alshazi

Assistant Professor of Pharmaceutical Biotechnology, King Saud University, Riyadh, Saudi Arabia
Read more
Dr. Rami Alzhrani

Dr. Rami Alzhrani

Assistant Professor in the Department of Pharmaceutics and Industrial Pharmacy College of Pharmacy, Taif University, Saudi Arabia
Read more
Dr. Arwa Alsubait

Dr. Arwa Alsubait

researcher at the Medical Research Core Facility and Platforms department at King Abdullah International Medical research Center (KAIMRC)
Read more
Dr. Homood As Sobeai

Dr. Homood As Sobeai

Read more
ali

Dr. Ali Rizwan

Molecular Biologist and Microscopist
Read more
Dr Sheraz

Dr Sheraz Gul

Fraunhofer-IME SP Schnackenburgallee 114 D-22525 Hamburg, Germany
Read more
committee

scientific and Organizing
committee

Dr. Naif Alharbi

Dr. Naif Alharbi

Forum Co-Chairman,
Read more
Dr. Alomair

Dr. Lamia Alomair

Head of A.I. and Bioinformatics at King Abdullah International Medical Research Center (KAIMRC), and an affiliated faculty member at George Mason University
Read more
DR. IMADUL ISLAM

DR. IMADUL ISLAM

Senior Scientist, KAIMRC, KSA
Read more
Dr. Abdulrhman Aljouie

Dr. Abdulrhman Aljouie

AI KAIMRC, KSA
Read more
1

Dr. Ahmed M. Salman

BSc, MSc, DPhil (Oxon)
Read more
2

Dr. Gene Garrard Olinger

Principal Advisor, Science; Global Health Surveillance & Diagnostic Division
Read more
5

DR. BARRAK AL SOMAIE

Operations Director
Read more
6

Dr. Bader Aldebasi

Assistant Professor of Radiology
Read more
7

Dr. Ibraheem A. Bushnak

Head of Research Training & Development Section
Read more
8

Dr. Julia Michelotti

Principal Scientist
Read more
13

Dr. Abdullah Al-Shuhri

Manager National Medical Products
Read more
Dr. Hashem O. Alsaab

Hashem O. Alsaab, PhD, PharmD

Assistant Professor of Pharmaceutics and Pharmaceutical Technology- Taif University -President of Pharmaceutical Scientists Group- Saudi Pharmaceutical Society (PSG-SPS)
Read more
Dr. Aiman Altamimi

Dr. Aiman Altamimi

General Director- University Relations and Media Affairs at King Saud Bin Abdulaziz University for Heath-Sciences (KSAU-HS) and King Abdullah International Medical Research Centre (KAIMRC)
Read more
Dr. Bahauddeen Alrfaei 1

Dr. Bahauddeen Alrfaei

Scientist in the Dept. of Cellular Therapy and Cancer Research at King Abdullah International Research Center

Dr. Bahauddeen Alrfaei is a Scientist in the Dept. of Cellular Therapy and Cancer Research at King Abdullah International Research Center. He earned his PhD in Cellular and Molecular Pathology from the University of Wisconsin Madison, USA. Later, he did a postdoctoral fellowship at Stanford University, USA. Dr. Alrfaei research focus is stem cells biology, neural development, cancer stem cells and metabolic diseases. He is a consultant for multiple governmental institutions such as Saudi FDA and Universities such as Majmaah university. He published more than 30 peer reviewed scientific papers. He currently work on glioblastoma therapeutic targets and Metabolic disorders biology of some rare diseases.

Read more
Dr. Bandar Alghanem

Dr. Bandar Alghanem

Dr. Alghanem is the Head of Proteomics and Metabolomics, King Abdullah International Medical Research Center (KAIMRC). He received his Bachelor Degree in Biochemistry from King Saud University in 2003. He obtained his master degree in Advanced Genomic and Proteomic sciences from The University of Nottingham, UK (2010). Dr.Alghanem completed his PhD in Pharmaceutical sciences from University of Geneva in 2016. He completed one year post-doctoral fellowship in Proteomics at The Scripps Research Institute, California, USA (2018). Currently, Dr.Algahnem works is focused on developing tools mass spectrometry including Proteomics and Metabolomics. He is involving in multiple projects including cancer, infectious disease, rare disease and others.

Read more
Dr. Sahar S. Alghamdi

Dr. Sahar S. Alghamdi

computational chemist and assistant professor of Medicinal Chemistry at King Saud bin Abdulaziz University for Health Sciences (KSAU-HS)

Dr. Sahar S. Alghamdi is a computational chemist and assistant professor of Medicinal Chemistry at King Saud bin Abdulaziz University for Health Sciences (KSAU-HS). She received her master’s degree from the University of Florida (UF) and obtained her Ph.D. degree in Medicinal Chemistry from the University of Tennessee Health Science Center (UTHSC). Her current funded research projects are focused on discovering the potential biological activities of natural products and small synthetic molecules using experimental in-vitro and in-vivo methods. Moreover, utilizing multiple computational tools to predict the pharmacokinetic properties, molecular targets, toxicity, CYP-P450 enzyme inhibition, homology models, and molecular docking and dynamic simulations for protein-ligand complexes. Dr. Alghamdi has been actively engaged in several activities such as community services, research projects, committees, student mentoring, research seminars, and scientific conferences.

Read more

Therapeutics Discovery. 10-11-12 October 2023
Contact us

Contacts
KSAU-HS, Al Hars Al Watani, Ar Rimayah Riyadh 14611 Saudi Arabia
KAIMRC-Therapeutics@ngha.med.sa
LINKS
  • Therapeutics Discovery Conference
  • Objectives
  • About Therapeutics Discovery Conference
© 2021 KAIMRC - Advance Computing & Technologies, All Rights Reserved.